Authors: De Maulmont, C Cherel, P Ouhioun, O Becette, V Stevens, D Plantet, MM Hagay, C

Citation: C. De Maulmont et al., Advances in mammary imaging for fourty years., PATH BIOL, 48(9), 2000, pp. 801-811

Authors: Bouchet, C Hacene, K Martin, PM Becette, V Tubiana-Hulin, M Lasry, S Oglobine, J Spyratos, F

Citation: C. Bouchet et al., Plasminogen activator system type-urokinase and its prognostic impact of adissemination risk index in breast cancer., PATH BIOL, 48(9), 2000, pp. 825-831

Authors: Lebret, T Becette, V Herve, JM Molinie, V Barre, P Lugagne, PM Gentille, A Baglin, AC Botto, H

Citation: T. Lebret et al., Prognostic value of MIB-1 antibody labeling index to predict response to bacillus Calmette-Guerin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer, EUR UROL, 37(6), 2000, pp. 654-659

Authors: Lebret, T Becette, V Colau, A Herve, JM Molinie, V Barre, P Lugagne-Delpon, PM Gentile, A Baglin, C Botto, H

Citation: T. Lebret et al., Study of monoclonal antibody Ki67 immunolabelling of renal cell carcinomaswith and without renal vein thrombosis., PROG UROL, 9(4), 1999, pp. 649-654

Authors: Bouchet, C Hacene, K Martin, PM Becette, V Tubiana-Hulin, M Lasry, S Oglobine, J Spyratos, F

Citation: C. Bouchet et al., Dissemination risk index based on plasminogen activator system components in primary breast cancer, J CL ONCOL, 17(10), 1999, pp. 3048-3057